<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0004308'>Ventricular arrhythmias</z:hpo> are important contributors to morbidity and mortality in patients with <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001663'>Ventricular fibrillation</z:hpo> accounts for the majority of <z:hpo ids='HP_0011420'>deaths</z:hpo> occurring in the <z:hpo ids='HP_0011009'>acute</z:hpo> phase of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, whereas sustained, monomorphic <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> due to reentry generated in the scar tissue develops most often in the setting of healed <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, especially in patients with lower left ventricular ejection fraction </plain></SENT>
<SENT sid="2" pm="."><plain>Despite determinant advances in population education and <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> management, the <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> risk in the overall population with <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> continues to be a major problem in clinical practice </plain></SENT>
<SENT sid="3" pm="."><plain>The initial evaluation of a patient presenting with <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> requires a 12-lead electrocardiogram, which can be helpful to confirm the diagnosis, suggest the presence of potential underlying <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e>, and identify the location of the <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> circuit </plain></SENT>
<SENT sid="4" pm="."><plain>An invasive electrophysiologic study is usually crucial to determine the mechanism of the <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> once induced and to provide guidance for ablation </plain></SENT>
<SENT sid="5" pm="."><plain>The approach for <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> ablation depends on several factors, including inducibility, sustainability, and clinical tolerance of <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The paper also reviews other therapeutic options for patients with <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> associated with <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo>, including antiarrhythmic drug therapy, surgical ablation, and current implantable cardioverter-defibrillator indications </plain></SENT>
</text></document>